Landau–Kleffner syndrome
| Landau–Kleffner syndrome | |
|---|---|
| Other names | Infantile acquired aphasia, acquired epileptic aphasia, aphasia with convulsive disorder |
| Landau–Kleffner syndrome is characterized by aphasia and an abnormal EEG | |
| Specialty | Neurology, psychiatry |
| Symptoms | Aphasia, inattention, hyperactivity, aggression, anxiety, seizures |
| Usual onset | Ages 3 to 7 |
| Duration | Lifelong |
| Treatment | Speech therapy, medication |
| Medication | Anticonvulsants, corticosteroids |
| Prognosis | Variable |
Landau–Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia,[1] or aphasia with convulsive disorder, is a rare neurological syndrome that develops during childhood.[2]
It is named after William Landau and Frank Kleffner, who characterized it in 1957 with a diagnosis of six children.[3][4]
- ^ "Landau–Kleffner syndrome" at Dorland's Medical Dictionary
- ^ "Landau Kleffner Syndrome - Symptoms, Causes, Treatment | NORD". rarediseases.org. Retrieved 21 April 2024.
- ^ Landau WM, Kleffner FR (August 1957). "Syndrome of acquired aphasia with convulsive disorder in children". Neurology. 7 (8): 523–30. doi:10.1212/wnl.7.8.523. PMID 13451887. S2CID 2093377. Reproduced as Landau WM, Kleffner FR (November 1998). "Syndrome of acquired aphasia with convulsive disorder in children. 1957". Neurology. 51 (5): 1241, 8 pages following 1241. doi:10.1212/wnl.51.5.1241-a. PMID 9867583. S2CID 45332481.
- ^ "Landau-Kleffner Syndrome (LKS or Infantile Acquired Aphasia)" (medicinenet). Medscape part of WebMD Health Professional Network.